Radiation oncology firm Accuray said it has now made its InCise multileaf collimator (MLC) for the CyberKnife M6 system available in the international markets in which it is approved for sale.
InCise MLC recently was successfully evaluated by Erasmus MC Cancer Institute in Rotterdam, the Netherlands, according to the vendor. It was launched commercially in the U.S. in February.
Accuray plans to show InCise MLC at the upcoming European Society for Radiotherapy and Oncology (ESTRO) meeting in Barcelona, Spain.
